Copyright
©The Author(s) 2016.
World J Hepatol. Dec 28, 2016; 8(36): 1610-1616
Published online Dec 28, 2016. doi: 10.4254/wjh.v8.i36.1610
Published online Dec 28, 2016. doi: 10.4254/wjh.v8.i36.1610
Figure 3 Serum b-GGT/t-GGT, s-GGT/t-GGT, f-GGT/t-GGT, b-GGT/s-GGT and s-GGT/f-GGT ratios in patients with biopsy-proven non-alcoholic fatty liver disease, biopsy-proven alcoholic liver disease and the controls group.
ALD: Alcoholic liver disease; NAFLD: Non-alcoholic fatty liver disease; GGT: Gamma-glutamyltransferase; b-GGT: Big-GGT; t-GGT: Total-GGT; s-GGT: Small-GGT; f-GGT: Free-GGT; ns: No significant differences.
- Citation: Sueyoshi S, Sawai S, Satoh M, Seimiya M, Sogawa K, Fukumura A, Tsutsumi M, Nomura F. Fractionation of gamma-glutamyltransferase in patients with nonalcoholic fatty liver disease and alcoholic liver disease. World J Hepatol 2016; 8(36): 1610-1616
- URL: https://www.wjgnet.com/1948-5182/full/v8/i36/1610.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i36.1610